Clinical features and prognostic analysis of transarterial chemoembolization combined with targeted immunotherapy in the treatment of patients with hepatitis B virus-related intermediate- and advanced-stage hepatocellular carcinoma with secondary cholestas  

作　　者：王柠柠 WANG Ningning(Dept Infect Dis,Affil Hosp,Xuzhou Med Univ,Xuzhou 221000)

机构地区：[1]Dept Infect Dis,Affil Hosp,Xuzhou Med Univ,Xuzhou 221000

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第1期51-52,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To study the clinical features and prognostic impact of transarterial chemoembolization(TACE),immune checkpoint inhibitors (ICIs),and tyrosine kinase inhibitors (TKIs) combination therapy regimens in the treatment of patients with hepatitis B virus-related intermediate-and advanced-stage hepatocellular carcinoma with secondary cholestasis.

关 键 词：PATIENTS HEPATOCELLULAR ARTERIAL 

分 类 号：R735.7[医药卫生—肿瘤]